Why the study?
Does intravenous esmolol alter hemodynamic parameters in male patients undergoing routine cardiac catheterization?
Does intravenous esmolol alter hemodynamic parameters in male patients undergoing routine cardiac catheterization?
Esmolol provides effective beta-blockade with an ultrashort half-life, allowing for rapid reversal of hemodynamic effects and offering a safe option for critically ill patients.
No takes yet. Share an insight, caveat, or question.
Esmolol's transient hemodynamic reductions during catheterization warrant caution in unstable patients; single-case data leaves open broader applicability.
Askenazi et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: